Dallas, TX -- (SBWire) -- 07/23/2010 -- According to the new market research report “Bioinformatics Market – Advanced Technologies, Global Forecast and Winning Imperatives (2009-2014)”, published by MarketsandMarkets (www.marketsandmarkets.com), the global bioinformatics market is expected to reach a $8.3 billion by 2014 at a high CAGR of 24.8% from 2009-2014. While knowledge management formed the largest submarket is 2009 at $1.3 billion, the bioinformatics platforms market is expected to have greatest market share in 2014 at an estimated $3.9 billion due to rising demand from U.S. and Europe.
Browse in-depth TOC on Bioinformatics Market.
Early buyers will receive 10% customization of reports
http://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html
The bioinformatics platforms market is growing at a significant pace with the increasing demand from U.S. and Europe. This trend is supported by the increasing demand for sequencing platforms with increasing life science research using techniques such as gene expression analysis, sequence analysis, and protein expression analysis.
Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trials for drug discovery.
Pharmaceutical companies have increased their focus on process improvement and quality in the current competitive scenario, as there is little scope for price escalation and product differentiation.
SCOPE AND FORMAT
The report analyzes the global bioinformatics market into respective segments:
• Bioinformatics platforms
• Content/knowledge management tools
• Bioinformatics services
• Bioinformatics applications
Analyst Briefing Presentation On Bioinformatics Market – Advanced Technologies, Global Forecast And Winning Imperatives (2009 – 2014) To Be Held On 5th Aug 2010
The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on Bioinformatics Market – Advanced Technologies, Global Forecast And Winning Imperatives (2009 – 2014) to be held on 5th Aug 2010.
To register your participation, please click here
http://www.marketsandmarkets.com/AnalystBriefing/bioinformatics-market.asp
About MarketsandMarkets
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com
Contact:
Ms. Sunita
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com
http://www.marketsandmarkets.com
http://marketsandmarkets.wordpress.com/
http://marketsandmarkets.blogspot.com/
MarketsandMarkets: Global Bioinformatics Market Worth $8.3 Billion by 2014
Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trials for drug discovery.